Total mesorectal excision of initially unresectable locally advanced rectal cancer infiltrating the pelvic wall after treatment with FOLFOX4 plus bevacizumab and preoperative chemoradiation: Report of a case

Surgery Today

Volumn 42, Issue 1, 2012, Pages 75-79

  Itatani, Yoshiro ^a   Akiyoshi, Takashi ^a   Kuroyanagi, Hiroya ^a   Yamakawa, Keiko ^a   Noaki, Rota ^a   Konishi, Tsuyoshi ^a   Fujimoto, Yoshiya ^a   Ueno, Masashi ^a   Oya, Masatoshi ^a   Suenaga, Mitsukuni ^a   Yamaguchi, Toshiharu ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Bevacizumab; Chemoradiotherapy; FOLFOX4; Rectal cancer

Indexed keywords

ANTIHYPERTENSIVE AGENT; BEVACIZUMAB; DOXIFLURIDINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CASE REPORT; CHEMORADIOTHERAPY; COLONOSCOPY; COLOSTOMY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIGITAL RECTAL EXAMINATION; DRUG DOSE REDUCTION; HUMAN; HYPERTENSION; LAPAROSCOPIC SURGERY; MALE; MELENA; MICROSCOPY; MULTIPLE CYCLE TREATMENT; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE RADIOTHERAPY; RECTUM CANCER; SURGICAL TECHNIQUE; TOTAL MESORECTAL EXCISION;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; ORGANOPLATINUM COMPOUNDS; PELVIS; RECTAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84857792195     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-011-0004-9     Document Type: Article

References (19)

1. RJ Heald RD Ryall 1986 Recurrence and survival after total mesorectal excision for rectal cancer Lancet 1 1479 1482 2425199 10.1016/S0140-6736(86) 91510-2 1:STN:280:DyaL283lsFylug%3D%3D (Pubitemid 16095660)
2. H Nelson DJ Sargent 2001 Refining multimodal therapy for rectal cancer N Engl J Med 345 690 692 11547725 10.1056/NEJM200108303450910 1:STN:280: DC%2BD3Mvps1ersQ%3D%3D
3. R Sauer H Becker W Hohenberger C Rodel C Wittekind R Fietkau, et al. 2004 Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731 1740 15496622 10.1056/NEJMoa040694 1:CAS:528:DC%2BD2cXovFSksbo%3D (Pubitemid 39383208)
4. NA Janjan VS Khoo J Abbruzzese R Pazdur R Dubrow KR Cleary, et al. 1999 Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience Int J Radiat Oncol Biol Phys 44 1027 1038 10421535 10.1016/S0360-3016(99)00099-1 1:STN:280:DyaK1Mzksl2jsQ%3D%3D (Pubitemid 29342903)
5. C Emmanouilides G Sfakiotaki N Androulakis K Kalbakis C Christophylakis A Kalykaki, et al. 2007 Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study BMC Cancer 7 91 17537235 10.1186/1471-2407-7-91 (Pubitemid 46995467)
6. CG Willett DG Duda BG Czito JC Bendell JW Clark RK Jain 2007 Targeted therapy in rectal cancer Oncology (Williston Park) 21 1055 1065 (Pubitemid 47347773)
7. ID Nagtegaal P Quirke 2008 What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26 303 312 18182672 10.1200/JCO.2007.12.7027
8. MJ Gosens RA Klaassen I Tan-Go HJ Rutten H Martijn AJ van den Brule, et al. 2007 Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma Clin Cancer Res 13 6617 6623 18006762 10.1158/1078-0432.CCR-07-1197 1:CAS:528:DC%2BD2sXhtlSmu7nP (Pubitemid 350206796)
9. E Kapiteijn CA Marijnen ID Nagtegaal H Putter WH Steup T Wiggers, et al. 2001 Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 638 646 11547717 10.1056/NEJMoa010580 1:STN:280:DC%2BD3Mvps1ektw%3D%3D
10. CA Marijnen ID Nagtegaal E Klein Kranenbarg J Hermans CJ van de Velde JW Leer, et al. 2001 No downstaging after short-term preoperative radiotherapy in rectal cancer patients J Clin Oncol 19 1976 1984 11283130 1:STN:280: DC%2BD3M3js1yltA%3D%3D (Pubitemid 32702542)
11. JF Bosset G Calais L Mineur P Maingon L Radosevic-Jelic A Daban, et al. 2005 Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921 J Clin Oncol 23 5620 5627 16009958 10.1200/JCO.2005.02.113 1:CAS:528:DC%2BD2MXhtVersr%2FF
12. HK Sanoff DJ Sargent ME Campbell RF Morton CS Fuchs RK Ramanathan, et al. 2008 Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741 J Clin Oncol 26 5721 5727 19001325 10.1200/JCO.2008.17.7147 1:CAS:528:DC%2BD1MXotFemtg%3D%3D
13. H Hurwitz L Fehrenbacher W Novotny T Cartwright J Hainsworth W Heim, et al. 2004 Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2335 2342 15175435 10.1056/NEJMoa032691 1:CAS:528:DC%2BD2cXks1Gjt74%3D (Pubitemid 38702844)
14. H Konno M Yamamoto M Ohta 2010 Recent concepts of antiangiogenic therapy Surg Today 40 494 500 20496129 10.1007/s00595-009-4150-2
15. G Masi F Loupakis L Pollina E Vasile S Cupini S Ricci, et al. 2009 Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases Ann Surg 249 420 425 19247029 10.1097/SLA.0b013e31819a0486
16. T Delaunoit SR Alberts DJ Sargent E Green RM Goldberg J Krook, et al. 2005 Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741 Ann Oncol 16 425 429 15677624 10.1093/annonc/mdi092 1:STN:280:DC%2BD2M%2FptVGkug%3D%3D (Pubitemid 40458319)
17. FA Calvo FJ Serrano JA Diaz-Gonzalez M Gomez-Espi E Lozano R Garcia, et al. 2006 Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation Ann Oncol 17 1103 1110 16670204 10.1093/annonc/mdl085 1:STN:280:DC%2BD28zotVarsw%3D%3D (Pubitemid 43985246)
18. YJ Chua Y Barbachano D Cunningham JR Oates G Brown A Wotherspoon, et al. 2010 Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial Lancet Oncol 11 241 248 20106720 10.1016/S1470-2045(09)70381-X 1:CAS:528:DC%2BC3cXisFGrsbY%3D
19. C Fernández-Martos C Pericay J Aparicio A Salud M Safont B Massuti, et al. 2010 Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study J Clin Oncol 28 859 865 20065174 10.1200/JCO.2009.25.8541